Incannex Healthcare Inc.
IXHL
$0.35
-$0.02-4.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 68.69% | -37.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 73.72% | 12.86% | |||
| Operating Income | -73.72% | -13.19% | |||
| Income Before Tax | -696.45% | 32.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -696.45% | 32.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -696.45% | 32.68% | |||
| EBIT | -73.72% | -13.19% | |||
| EBITDA | -75.30% | -15.25% | |||
| EPS Basic | -88.17% | 39.56% | |||
| Normalized Basic EPS | -147.20% | 54.69% | |||
| EPS Diluted | -88.17% | 39.56% | |||
| Normalized Diluted EPS | -147.20% | 54.69% | |||
| Average Basic Shares Outstanding | 323.28% | 11.39% | |||
| Average Diluted Shares Outstanding | 323.28% | 11.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||